• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Although substantial progress has been made in the prevention, diagnosis, and treatment of
acute aortic dissection, it remains a complex cardiovascular event, with a high immediate …

Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

After 15 years of successive randomized, controlled trials, indications for transcatheter aortic
valve replacement (TAVR) are rapidly expanding. In the coming years, this procedure could …

Indications for transcatheter aortic valve implantation (TAVI) have expanded in many
countries to include patients with aortic stenosis who are at low surgical risk, and a similar …

These guidelines, endorsed by both the EACTS and STS, represent the official viewpoint on
this topic. They show a commitment to ongoing improvement, as regular updates will be …

In this EACVI clinical scientific update, we will explore the current use of multi-modality
imaging in the diagnosis, risk stratification, and follow-up of patients with aortic stenosis, with …

Bicuspid aortic valve is the most common congenital heart disease and exposes patients to
an increased risk of aortic dilation and dissection. Aortic dilation is a slow, silent process …

Minimally invasive strategies to treat valvular heart disease have emerged over the past 2
decades. The use of transcatheter aortic valve replacement in the treatment of severe aortic …

Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …